RetinalGenix Technologies (RTGN) Share-based Compensation (QoQ) (2021 - 2026)
RetinalGenix Technologies (RTGN) Share-based Compensation (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn |
| 2 | Stryker | 129.56 Bn | 126.09 Bn | 4.50 Bn |
| 3 | Medtronic | 119.95 Bn | 110.73 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.85 Bn | 73.31 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.69 Bn | 48.44 Bn | 1.35 Bn |
| 6 | Dexcom | 34.55 Bn | 32.60 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.11 Bn | 32.00 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn |
| 9 | Steris | 23.22 Bn | 22.73 Bn | 684.20 Mn |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -96.44% |
| Dec 31, 2025 | 1.45% |
| Sep 30, 2025 | 10.81% |
| Jun 30, 2025 | 7.87% |
| Mar 31, 2025 | -89.78% |
| Dec 31, 2024 | 665.83% |
| Sep 30, 2024 | 40.40% |
| Jun 30, 2024 | -87.82% |
| Mar 31, 2024 | 243.55% |
| Dec 31, 2023 | 17.66% |
| Sep 30, 2023 | 446.03% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | -86.61% |
| Dec 31, 2022 | 729.51% |
| Sep 30, 2022 | 28.41% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | -36.23% |
| Jun 30, 2021 | -22.57% |